BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21895545)

  • 1. Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.
    Shah N; Cabanillas F; McIntyre B; Feng L; McLaughlin P; Rodriguez MA; Romaguera J; Younes A; Hagemeister FB; Kwak L; Fayad L
    Leuk Lymphoma; 2012 Jan; 53(1):50-6. PubMed ID: 21895545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
    Christiansen I; Sundström C; Kälkner KM; Bring J; Tötterman TH
    Eur J Haematol; 1999 Mar; 62(3):202-9. PubMed ID: 10089899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Iijima K
    Leuk Res; 2002 Mar; 26(3):241-8. PubMed ID: 11792412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
    Christiansen I; Sundström C; Kälkner KM; Bring J; Tötterman TH
    Eur J Haematol; 1998 Nov; 61(5):311-8. PubMed ID: 9855246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1: biomarkers in search of validation in lymphomas.
    Martin P
    Leuk Lymphoma; 2012 Jan; 53(1):1-2. PubMed ID: 22035419
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
    Lei KI; Johnson PJ
    Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
    Sasaki K; Niitsu N
    Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
    Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
    Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
    Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
    Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis.
    Kuessel L; Wenzl R; Proestling K; Balendran S; Pateisky P; Yotova ; Yerlikaya G; Streubel B; Husslein H
    Hum Reprod; 2017 Apr; 32(4):770-779. PubMed ID: 28333208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular adhesion molecule-1(ICAM-1), CD44s expression and serum level of sICAM-1 in disseminated non-Hodgkin's lymphoma: correlation with overall survival.
    Aboul-Enein M; El-Sayed GM; El-Maghraby S; Abd-Elatif NA; Abd Elwahab GA; Elbasmy AA
    J Egypt Natl Canc Inst; 2004 Dec; 16(4):244-51. PubMed ID: 16116502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease.
    Morisaki N; Saito I; Tamura K; Tashiro J; Masuda M; Kanzaki T; Watanabe S; Masuda Y; Saito Y
    Atherosclerosis; 1997 May; 131(1):43-8. PubMed ID: 9180243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble adhesion molecule profiling in preoperative infants with biliary atresia.
    Davenport M; Gonde C; Narayanaswamy B; Mieli-Vergani G; Tredger JM
    J Pediatr Surg; 2005 Sep; 40(9):1464-9. PubMed ID: 16150350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble vascular cell adhesion molecule-1 (sVCAM-1) is an independent prognostic marker in Hodgkin's disease.
    Christiansen I; Sundström C; Enblad G; Tötterman TH
    Br J Haematol; 1998 Aug; 102(3):701-9. PubMed ID: 9722296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation and prognostic value of serum soluble ICAM-1, beta-2 microglobulin, and IL-2alphaR levels in non-Hodgkin's lymphoma.
    Pérez-Encinas M; Quintas A; Bendaña A; Rabuñal MJ; Bello JL
    Leuk Lymphoma; 1999 May; 33(5-6):551-8. PubMed ID: 10342582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis.
    Kobayashi H; Horikoshi K; Long L; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2001 Aug; 36(8):1297-301. PubMed ID: 11479880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy.
    Nowak M; Wielkoszyński T; Marek B; Kos-Kudła B; Swietochowska E; Siemińska L; Kajdaniuk D; Głogowska-Szelag J; Nowak K
    Clin Exp Med; 2008 Sep; 8(3):159-64. PubMed ID: 18791689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels and differential expression of CD44 in childhood leukemia and malignant lymphoma: correlation with prognostic criteria and survival.
    Taçyildiz N; Cavdar AO; Yavuz G; Gözdaşoglu S; Unal E; Ertem U; Duru F; Ikinciogullari A; Babacan E; Kuzu I; Cin S
    Pediatr Int; 2001 Aug; 43(4):354-60. PubMed ID: 11472578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.